It said products marketed
to treat specific pains, such as migraines, were identical to its standard Nurofen product despite being priced higher.
 |
| Nurofen |
The manufacturer, Reckitt Benckiser, said it would comply and that it "did not set out to mislead consumers".
Australia's consumer watchdog brought the matter to court earlier this year.
The Federal Court of Australia said the products must be taken off Australian shelves within three months.
